World News
-
XLerateHealth Accelerator selects ten companies for incoming sixth cohort
World | News | 0 Comment | 26 Jul, 2018
XLerateHealth, an enterprise-focused healthcare accelerator that helps early-stage healthcare companies has announced it...Read more
-
GSK signs $300M genetic testing deal
World | News | 0 Comment | 26 Jul, 2018
Singapore- GlaxoSmithKline has made a $300 million equity investment in the Silicon Valley gene testing compan...Read more
-
NanoSphere receives patent for nanoparticle delivery of Cannabis
World | News | 0 Comment | 25 Jul, 2018
NanoSphere Health Sciences has been awarded a breakthrough patent, granting the biotech innovator full ownership over th...Read more
-
AstraZeneca sells European rights for heart failure treatment for $210M
World | News | 0 Comment | 24 Jul, 2018
Singapore - AstraZeneca has agreed to sell the European commercial rights to hypertension and heart...Read more
-
Biocept, UC collaborate on predicting disease recurrence in solid tumors
World | News | 0 Comment | 24 Jul, 2018
Singapore - Biocept, a leading commercial provider of liquid biopsy tests designed to provide physicians with clin...Read more
-
Tabula Rasa HealthCare’s SinfoníaRx releases RxCompanion 10.0 Software
World | News | 0 Comment | 24 Jul, 2018
Tabula Rasa HealthCare, Inc., a healthcare technology company optimizing medication safety has announced a new generatio...Read more
-
FDA approves Tibsovo for AML patients
World | News | 0 Comment | 23 Jul, 2018
Singapore – The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) tablets for the treatment of adult...Read more
-
Agios receives nod for ivosidenib
World | News | 0 Comment | 23 Jul, 2018
Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...Read more
-
Bayer to stop Essure sales at year-end
World | News | 0 Comment | 23 Jul, 2018
Singapore –Bayer AG will no longer sell its controversial female contraceptive implant Essure after December 31. T...Read more
-
FDA approves Pfizer's biosimilar
World | News | 0 Comment | 23 Jul, 2018
Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...Read more
-
Allergan strikes out with sovereign nation scheme to protect patents
World | News | 0 Comment | 23 Jul, 2018
Singapore – The U.S. Court of Appeals has affirmed the decision of the USPTO's Patent Trial and Appeal B...Read more
-
Azafaros to develop new treatments for rare metabolic disorders
World | News | 0 Comment | 23 Jul, 2018
Azafaros, a spin-off from Leiden University and Amsterdam UMC, focusing on the development of new therapies in the field...Read more
-
UK Government hosts roundtables with stakeholders from key life science businesses
World | News | 0 Comment | 23 Jul, 2018
The UK Government, last week, hosted the second in a series of roundtables with stakeholders from key life science busin...Read more
-
Kite announces collaboration with Gadeta
World | News | 0 Comment | 23 Jul, 2018
Kite, a Gilead Company and Gadeta B.V., a privately-held company focused on the discovery and development of novel cance...Read more
-
J&J sells global rights of SYLVANT to EUSA Pharma
World | News | 0 Comment | 21 Jul, 2018
EUSA Pharma (EUSA), a biopharmaceutical company focused on oncology and rare disease, has entered into a definitive agre...Read more
-
B. Braun to acquire bloodlines business of NxStage
World | News | 0 Comment | 20 Jul, 2018
Singapore – B. Braun Medical (B. Braun), a market leader in renal therapies, infusion therapy, and pain management...Read more
-
PTC to acquire Agilis Biotherapeutics for $200M
World | News | 0 Comment | 20 Jul, 2018
Singapore – PTC Therapeutics (New Jersey-based drug developer) agrees to acquire gene therapy developer Agilis Bio...Read more
-
World | News | 0 Comment | 20 Jul, 2018
Singapore – Aeglea BioTherapeutics, a clinical-stage biotechnology company that designs and develops innovative hu...Read more
